Skip to content
10-Q

Quarterly Report

AOXING PHARMACEUTICAL COMPANY, INC.

0001096906-15-001149

← back to feed
Filed
Nov 13, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Nov 13, 2015 74.3M sh
Short Term Debt Q1 2016 · Sep 30, 2015 $11.34M
Short Term Debt Q1 2016 · Jun 30, 2015 $12.48M
Stockholders Equity Q1 2016 · Sep 30, 2015 $14.74M
Stockholders Equity Q1 2016 · Jun 30, 2015 $11.24M
Current Liabilities Q1 2016 · Sep 30, 2015 $39.66M
Current Liabilities Q1 2016 · Jun 30, 2015 $41.24M
Current Assets Q1 2016 · Sep 30, 2015 $25.35M
Current Assets Q1 2016 · Jun 30, 2015 $21.1M
Total Assets Q1 2016 · Sep 30, 2015 $54.98M
Total Assets Q1 2016 · Jun 30, 2015 $53.04M
Capex Q1 2016 · Sep 30, 2014 $173.61K
Operating Cash Flow Q1 2016 · Sep 30, 2014 −$2.29M
Sga Expense Q1 2016 · Sep 30, 2014 $511.49K
Rd Expense Q1 2016 · Sep 30, 2014 $107.55K
Net Income Q1 2016 · Sep 30, 2014 −$2.41K
Operating Income Q1 2016 · Sep 30, 2014 $1.22M
Gross Profit Q1 2016 · Sep 30, 2014 $3.18M
Cost Of Revenue Q1 2016 · Sep 30, 2014 $1.39M